Kaye et al., 1986 - Google Patents
The metabolism and kinetics of doxazosin in man, mouse, rat and dog.Kaye et al., 1986
View PDF- Document ID
- 16814721763729842295
- Author
- Kaye B
- Cussans N
- Faulkner J
- Stopher D
- Reid J
- Publication year
- Publication venue
- British journal of clinical pharmacology
External Links
Snippet
The metabolic fate of doxazosin was investigated in man, mouse, rat and dog using 14C‐ labelled compound. Bioavailability and pharmacokinetic studies were also conducted with nonlabelled drug, using a specific hplc method. Following both oral and intravenous …
- 241000282414 Homo sapiens 0 title abstract description 49
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaye et al. | The metabolism and kinetics of doxazosin in man, mouse, rat and dog. | |
Mangner et al. | Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma | |
Martin et al. | Metabolic studies of salbutamol-3H: A new bronchodilator, in rat, rabbit, dog and man | |
Jardine et al. | Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy | |
DE69620467T2 (en) | RADIONUCLIDE MARKING OF VITAMIN B12 AND THEIR COENZYME | |
Teng et al. | Metoclopramide metabolism and determination by high‐pressure liquid chromatography | |
El Dareer et al. | Distribution and Metabolism of Vincristine in Mice, Rats, Dogs, and Monkeys 1, 2, 3 | |
CA1076481A (en) | Drug compositions | |
Tanayama et al. | Biotransformation of molsidomine (N-ethoxycarbonyl-3-morpholinosydnonimine), a new anti-anginal agent, in rats | |
Tremaine et al. | Characterization of a carbamic acid ester glucuronide of the secondary amine sertraline. | |
Philips et al. | Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl) thymine and 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine | |
Drach et al. | Species differences in the metabolism of diphenhydramine (Benadryl) | |
Arcamone et al. | Studies on the metabolism of ergoline derivatives: metabolism of nicergoline in man and in animals | |
Goehl et al. | Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey | |
Grislain et al. | The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. | |
Thomas et al. | Metabolism of Minoxidil, a New Hypotensive Agent 11: Biotransformation following Oral Administration to Rats, Dogs, and Monkeys | |
US5208338A (en) | Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans | |
Kamm et al. | Metabolism of chlorpheniramine-3H by the rat and dog | |
Stramentinoli et al. | Influence of S-adenosyl-L-methionine on irreversible binding of ethynylestradiol to rat liver microsomes, and its implication in bile secretion | |
Thomas et al. | Metabolism of minoxidil, a new hypotensive agent I: Absorption, distribution, and excretion following administration to rats, dogs, and monkeys | |
Shargel et al. | Physiological disposition and metabolism of (3H) bitolterol in man and dog. | |
Dicarlo et al. | Prazepam metabolism by dogs | |
Gombar et al. | Pharmacokinetics, metabolism, and disposition of 6-chloro-2, 3, 4, 5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) in rats and dogs. | |
Furst | Studies on the distribution and excretion of a metabolite of guanethidine in the rat | |
Wong et al. | Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog. |